okbet wiki
Artist explores the human cost of conservation
CONWAY, Ark. (AP) — Elias Cato scored 23 points as Central Arkansas beat UNC Asheville 92-83 in double overtime on Sunday. Jordan Morris made two free throws with one second left for UNC Asheville (2-3) to force overtime tied at 71. Fletcher Abee's 3-pointer with 33 seconds left in the first overtime tied the game at 79 and led to the second extra period. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get updates and player profiles ahead of Friday's high school games, plus a recap Saturday with stories, photos, video Frequency: Seasonal Twice a week
Some Democrats are frustrated over Joe Biden reversing course and pardoning Hunter
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCsTM), today announced that on November 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 117,000 shares of its common stock and 58,500 restricted stock units ("RSUs") to twelve (12) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4). The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Avidity, or following a bona fide period of non-employment, as an inducement material to such individuals' entering into employment with Avidity, pursuant to Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $43.65 per share, which is equal to the closing price of Avidity's common stock on The Nasdaq Global Market on November 20, 2024, or the vesting commencement date. The shares subject to the stock options will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter, subject to each employee's continued employment with Avidity on such vesting dates. The RSUs will vest in four equal installments on the first four anniversaries of the vesting commencement date, subject to each employee's continued employment with Avidity on such vesting dates. The awards are subject to the terms and conditions of the 2022 Inducement Plan and the terms and conditions of a stock option agreement or RSU agreement, as applicable, covering the grant. About Avidity Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCsTM). Avidity is revolutionizing the field of RNA with its proprietary AOCs, which are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Utilizing its proprietary AOC platform, Avidity demonstrated the first-ever successful targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare neuromuscular diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In addition, Avidity is broadening the reach of AOCs with its advancing and expanding pipeline including programs in cardiology and immunology through key partnerships. Avidity is headquartered in San Diego, CA. For more information about our AOC platform, clinical development pipeline and people, please visit www.aviditybiosciences.com and engage with us on LinkedIn and X . Investor Contact: Mike MacLean (619) 837-5014 investors@aviditybio.com Media Contact: Navjot Rai (619) 837-5016 media@aviditybio.com View original content to download multimedia: https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302313526.html SOURCE Avidity Biosciences, Inc.Baltimore Ravens head coach John Harbaugh gave a touching Christmas message Saturday after winning a spot in the coming NFL playoffs. After the game, Harbaugh told reporters that it was important to him and millions of others to focus on what the coming holiday actually means, Fox News reported. “I read this to the team in our postgame prayer, and it’s this – this is Mary. Mary, the mother of God, said this when she was with Elizabeth,” Harbaugh said. “She said this, ‘My soul magnifies the Lord, and my spirit rejoices in God, my Savior.’ So, I just want to wish everybody a Merry Christmas, happy holiday season, and rejoice,” Harbaugh continued. ️ pic.twitter.com/34kdUq73IZ — Baltimore Ravens (@Ravens) December 22, 2024 “Rejoice. Rejoice in life. Rejoice in your circumstances. Rejoice in the tough games. Rejoice in the losses. Rejoice in the wins like we’re blessed to do today as a football team, and just rejoice in the people that you love, the people that are close to you. Rejoice,” he recited. “We aren’t here on this Earth to worry about every little thing and spar with one another. We’re here to rejoice in one another and with one another and love one another. Let’s try to remember that this week. This is a big football week – it’s also a big life week. It’s a big spiritual week,” Harbaugh explained. Harbaugh and the Ravens bested the Steelers on Saturday and will next play the Houston Texans on Christmas Day. The Steelers are not out of the hunt, though. They will also play on Christmas Day against the Kansas City Chiefs. Follow Warner Todd Huston on Facebook at: facebook.com/Warner.Todd.Huston , or Truth Social @WarnerToddHuston
Moreover, the developers have taken great care to ensure that the map retains the game's distinctive visual style and cultural influences. Every detail, from the elegant calligraphy to the intricate illustrations, reflects the artistry and craftsmanship of traditional Chinese design. Players will find themselves not only using the map as a tool for navigation but also as a window into the captivating world of "Black Myth: Wukong."
In the world of agriculture, a new lifeline has emerged: the concept of a "lifeline straw." This metaphorical straw, believed to offer a saving grace in times of crisis, has now been firmly grasped by the corn industry. The question on many minds is whether this inflection point signals an impending transformation for corn, and how this subtle shift in market sentiment is likely to play out.Prime Minister Netanyahu's assertion that the Golan Heights is an "indivisible part of Israel" has drawn criticism from many countries, including the United States and key European allies. They argue that such a unilateral declaration undermines efforts to reach a peaceful resolution to the Israeli-Palestinian conflict and violates international law.
In conclusion, Meitu Xiuxiu's achievement of topping the App Store charts in Indonesia is a testament to the app's exceptional AI features, user-friendly interface, and powerful editing capabilities. By leveraging advanced technology to empower users with creative tools and effects, Meitu Xiuxiu has established itself as a leading photo editing app in the region, catering to the diverse needs of Indonesian smartphone users and setting a benchmark for excellence in the industry.
In conclusion, the "West Street Observations" platform serves as a beacon of critical thinking and social consciousness in today's media landscape. By going beyond the narrow focus on rights and delving into the complexities of social issues, the platform challenges readers to expand their understanding and empathy for others. In a world where rights are often contested and violated, the platform's heart lies in promoting justice, equality, and understanding for all.